Ipsen R&D France - Global
Ipsen R&D France
Loading...
  • Mediaarrow_down
      < Back
    • Media
    • Press Releases
    • Media Statements
    • Media Library
  • Investorsarrow_down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports and Accounts
    • Presentations
    • Corporate News
    • Financial Calendar
    • Investor Events
    • Shareholder Information
    • Share-Price Data
    • Regulated Information
    • Key Contacts
  • Partnering
  • Careersarrow_down
      < Back
    • Careers
    • Careers – 2
    • Working at Ipsen
    • Culture
  • Loading...
  • English  EN     Français  FR     EN  arrow_down
    • EnglishEN
    • FrançaisFR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Austria
    • Switzerland
    • UAE & Gulf
  • Home
  • Companyarrow_down
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Sciencearrow_down
      < Back
    • Science
    • Rare Disease
    • Neuroscience
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
  • Responsibilityarrow_down
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • Patients
    • People
    • Governance
  • Patientsarrow_down
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Lay Summaries
    • Collaborate with us
  • Stories
Back

Post navigation

Previous
Next

Ipsen R&D France

Ipsen R&D France

- 11 May 2023 - 0 mins read

Post navigation

Previous
Next

Related Locations

Boulogne Billancourt, siège social.
23 October 2024 0 mins read

Boulogne Billancourt, siège social.
IPSEN Saudi Arabia
04 July 2023 0 mins read

IPSEN Saudi Arabia
Ipsen Vietnam
13 May 2023 0 mins read

Ipsen Vietnam
Ipsen United States of America
13 May 2023 0 mins read

Ipsen United States of America
Ipsen United States of America
13 May 2023 0 mins read

Ipsen United States of America
Ipsen United States of America
13 May 2023 0 mins read

Ipsen United States of America
Ipsen United Kingdom
13 May 2023 0 mins read

Ipsen United Kingdom
Ipsen Manufacturing & R&D United Kingdom
13 May 2023 0 mins read

Ipsen Manufacturing & R&D United Kingdom
Ipsen R&D United Kingdom
13 May 2023 0 mins read

Ipsen R&D United Kingdom
Ipsen United Arab Emirates
13 May 2023 0 mins read

Ipsen United Arab Emirates

IPN price

€108.30

 €-0.70 (-0.64%)

  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy
  • Company
  • Responsibility
  • Patients
  • Stories
  • Annual Report
  • Contact us
Global
LinkedIn Twitter Facebook Instagram Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

Copyright © Ipsen Pharma. All rights reserved - 2023

You are now leaving the Ipsen group website.
To continue, please click on Continue?

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.